The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant (Q59206999)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 2002
edit
Language Label Description Also known as
English
The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant
scientific article published on 01 January 2002

    Statements

    The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit